TMEM106A's function might be co‐opted in gliomas to promote tumor aggressiveness, possibly through pathways that are dormant in other tissues of its microenvironment (i.e., immune cells) rather than directly impacting the tumor cells themselves. Here, TMEM106A is linked to central nervous system cancer.